Future treatments for hyperoxaluria

Primary Hyperoxaluria

Primary hyperoxalurias are rare recessive inherited inborn errors of glyoxylate metabolism. They are responsible for progressive renal involvement, which further lead to systemic oxalate deposition, which can even occur in infants. Primary hyperoxaluria type 1 is the most common form in Europe and is due to alanine-glyoxylate aminostransferase deficiency, a hepatic peroxisomal pyridoxin-depende...

Primary hyperoxaluria

Future possibilities for the development of treatments of leukemia.

after the event as an historian than before the event as a prophet. â€oeIt is therefore a formidable task even to at tempt crystal gazing at a time when so much work directed toward a solution of the problem under discussion is in progress all over the world. A good prophet is a person who has taken in all the relevant and established facts of a case and has digested them properly. Then from hi...

Future treatments for chronic obstructive pulmonary disease and its comorbidities.

The recognition that patients with chronic obstructive pulmonary disease (COPD) may have systemic manifestations and often suffer from comorbid conditions has important implications for therapy that require further research. The most likely link between COPD and extrapulmonary effects is that inflammation in the lung periphery "spills over" into the systemic circulation and effects on other org...

Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future Prospects

Ricin, a plant-derived toxin originating from the seeds of Ricinus communis (castor beans), is one of the most lethal toxins known, particularly if inhaled. Ricin is considered a potential biological threat agent due to its high availability and ease of production. The clinical manifestation of pulmonary ricin intoxication in animal models is closely related to acute respiratory distress syndro...